| Powder flow J Staniforth Pharmaceutics, The science of dosage form design, 197-210, 2002 | 334 | 2002 |
| The cohesive-adhesive balances in dry powder inhaler formulations I: direct quantification by atomic force microscopy P Begat, DAV Morton, JN Staniforth, R Price Pharmaceutical research 21 (9), 1591-1597, 2004 | 279 | 2004 |
| Delivery of oral drugs J Staniforth, M Tobyn US Patent 7,089,934, 2006 | 237 | 2006 |
| Sustained-release formulations utilizing pharmaceutical excipient having improved compressibility JN Staniforth, BE Sherwood, EA Hunter US Patent 5,741,524, 1998 | 237 | 1998 |
| Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers P Lucas, K Anderson, JN Staniforth Pharmaceutical research 15 (4), 562-569, 1998 | 237 | 1998 |
| The influence of relative humidity on particulate interactions in carrier-based dry powder inhaler formulations R Price, PM Young, S Edge, JN Staniforth International journal of pharmaceutics 246 (1), 47-59, 2002 | 209 | 2002 |
| Topical administration device M Tobyn, J Staniforth, S Mills, G Paterson, C Althorpe US Patent App. 10/488,169, 2002 | 188 | 2002 |
| Polysaccharide gum carrier A Baichwal, JN Staniforth US Patent 5,612,053, 1997 | 184* | 1997 |
| Forming aqueous slurry of microcrystalline cellulose and compressibility augmenting agent, drying to form agglomerated particles, adding active agent, incorporating sustained … JN Staniforth, BE Sherwood, EA Hunter US Patent 5,858,412, 1999 | 171* | 1999 |
| The cohesive-adhesive balances in dry powder inhaler formulations II: Influence on fine particle delivery characteristics P Begat, DAV Morton, JN Staniforth, R Price Pharmaceutical research 21 (10), 1826-1833, 2004 | 168 | 2004 |
| Physicochemical comparison between microcrystalline cellulose and silicified microcrystalline cellulose MJ Tobyn, GP McCarthy, JN Staniforth, S Edge International journal of pharmaceutics 169 (2), 183-194, 1998 | 159 | 1998 |
| Controlled release insufflation carrier for medicaments A Baichwal, JN Staniforth US Patent 5,738,865, 1998 | 155 | 1998 |
| Drug delivery JN Staniforth US Patent 5,004,614, 1991 | 153* | 1991 |
| Enhancement of small particle size dry powder aerosol formulations using an ultra low density additive P Lucas, K Anderson, UJ Potter, JN Staniforth Pharmaceutical research 16 (10), 1643-1647, 1999 | 146 | 1999 |
| Directly compressible sustained release excipient AR Baichwal, JN Staniforth US Patent 4,994,276, 1991 | 146 | 1991 |
| The influence of force control agents on the cohesive-adhesive balance in dry powder inhaler formulations P Begat, R Price, H Harris, DAV Morton, JN Staniforth Kona 23, 109-121, 2005 | 136 | 2005 |
| Orally administered controlled drug delivery system providing temporal and spatial control N Talwar, H Sen, JN Staniforth US Patent 6,261,601, 2001 | 133 | 2001 |
| Aerosol electrostatics I: properties of fine powders before and after aerosolization by dry powder inhalers PR Byron, J Peart, JN Staniforth Pharmaceutical research 14 (6), 698-705, 1997 | 121 | 1997 |
| The mechanical properties of compacts of microcrystalline cellulose and silicified microcrystalline cellulose S Edge, DF Steele, A Chen, MJ Tobyn, JN Staniforth International journal of pharmaceutics 200 (1), 67-72, 2000 | 120 | 2000 |
| Xnathan gum, galactomannan gum AR Baichwal, JN Staniforth US Patent 5,128,143, 1992 | 115* | 1992 |
